Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.71 - $2.43 $9,707 - $33,222
-13,672 Closed
0 $0
Q1 2022

Jun 30, 2022

SELL
$2.31 - $5.13 $2,541 - $5,643
-1,100 Reduced 7.45%
13,672 $33,000
Q4 2021

Feb 15, 2022

SELL
$4.45 - $8.09 $1,246 - $2,265
-280 Reduced 1.86%
14,772 $70,000
Q3 2021

Oct 29, 2021

SELL
$6.94 - $8.85 $5,316 - $6,779
-766 Reduced 4.84%
15,052 $118,000
Q2 2021

Aug 16, 2021

BUY
$7.45 - $16.27 $117,844 - $257,358
15,818 New
15,818 $128,000

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.